All News

After many years of speculation, a number of biosimilar drugs are hitting the U.S. market.

A tricky labeling system could be affecting your patients.

Generic drugs make up 90% of prescriptions.

Where are today's grads going (and why are there fewer of them)?

Savings from generic and biosimilar drugs are making PBMs and pharmacies, as well as patients, happy.

Biosimilars are starting to come on the market, but some have questions about their safety.

Pharmacists will have a central role in educating about biosimilar drugs.

Biosimilars are now being dispensed from community pharmacies.

The provided droppers may have been mislabeled.

A 5% drop in MMR vaccine use could lead to as much as $4.1 million in health-care costs.

Parents of teenagers are often unaware that their teen children have not had all the vaccinations they need.

Maybe the health-care industry could learn something from Pete Kreckel's mother.

How can we better engage patients for greater adherence rates?

Pharmacists are a source of education for students and parents.

Why are residency programs becoming harder to find?

Patients need more help managing complicated meds than ever-and pharmacists are there to help.

The first test store in Des Plaines could be just the start.

The FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.

The failed Rite Aid/Walgreens merger might mean the end of business as usual.

Is your pharmacy's refrigerator maintaining the right temperature?

International Laboratories recalling one lot of bottles labeled 40-mg pravastatin.

When drug prices spike, health-care providers are forced to make tough choices.

FDA is alerting health professionals to a sterility breach with Vital Rx Inc. products.

Class action lawsuits claim that chains colluded with PBMs to overbill customers.

New research suggests that the latest trend in opioids may not be so helpful.

The recall affects a variety of distributors.

Pharmacy chains are forcing lower generic prices for their customers.

A youth education campaign about e-cigarettes is part of FDA’s tobacco/nicotine plan.